471 related articles for article (PubMed ID: 21499247)
1. Exome sequencing identifies GRIN2A as frequently mutated in melanoma.
Wei X; Walia V; Lin JC; Teer JK; Prickett TD; Gartner J; Davis S; ; Stemke-Hale K; Davies MA; Gershenwald JE; Robinson W; Robinson S; Rosenberg SA; Samuels Y
Nat Genet; 2011 May; 43(5):442-6. PubMed ID: 21499247
[TBL] [Abstract][Full Text] [Related]
2. Genetic and Functional Analysis of GRIN2A in Tumor Samples.
Prickett TD; Gartner JJ; Samuels Y
Methods Mol Biol; 2017; 1677():93-116. PubMed ID: 28986867
[TBL] [Abstract][Full Text] [Related]
3. Melanoma researchers have a reason to GRIN: melanoma yields more of its secrets to exome sequencing.
Meltzer P
Pigment Cell Melanoma Res; 2011 Aug; 24(4):590-1. PubMed ID: 21592317
[No Abstract] [Full Text] [Related]
4. Selected GRIN2A mutations in melanoma cause oncogenic effects that can be modulated by extracellular glutamate.
D'mello SA; Joseph WR; Green TN; Leung EY; During MJ; Finlay GJ; Baguley BC; Kalev-Zylinska ML
Cell Calcium; 2016 Dec; 60(6):384-395. PubMed ID: 27659111
[TBL] [Abstract][Full Text] [Related]
5. Somatic mutation of GRIN2A in malignant melanoma results in loss of tumor suppressor activity via aberrant NMDAR complex formation.
Prickett TD; Zerlanko BJ; Hill VK; Gartner JJ; Qutob N; Jiang J; Simaan M; Wunderlich J; Gutkind JS; Rosenberg SA; Samuels Y
J Invest Dermatol; 2014 Sep; 134(9):2390-2398. PubMed ID: 24739903
[TBL] [Abstract][Full Text] [Related]
6. Whole exome sequencing identifies a recurrent RQCD1 P131L mutation in cutaneous melanoma.
Wong SQ; Behren A; Mar VJ; Woods K; Li J; Martin C; Sheppard KE; Wolfe R; Kelly J; Cebon J; Dobrovic A; McArthur GA
Oncotarget; 2015 Jan; 6(2):1115-27. PubMed ID: 25544760
[TBL] [Abstract][Full Text] [Related]
7. Rare SF3B1 R625 mutations in cutaneous melanoma.
Kong Y; Krauthammer M; Halaban R
Melanoma Res; 2014 Aug; 24(4):332-4. PubMed ID: 24709888
[TBL] [Abstract][Full Text] [Related]
8. Novel TRRAP mutation causes autosomal dominant non-syndromic hearing loss.
Xia W; Hu J; Ma J; Huang J; Wang X; Jiang N; Zhang J; Ma Z; Ma D
Clin Genet; 2019 Oct; 96(4):300-308. PubMed ID: 31231791
[TBL] [Abstract][Full Text] [Related]
9. Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma.
Gartner JJ; Parker SC; Prickett TD; Dutton-Regester K; Stitzel ML; Lin JC; Davis S; Simhadri VL; Jha S; Katagiri N; Gotea V; Teer JK; Wei X; Morken MA; Bhanot UK; ; Chen G; Elnitski LL; Davies MA; Gershenwald JE; Carter H; Karchin R; Robinson W; Robinson S; Rosenberg SA; Collins FS; Parmigiani G; Komar AA; Kimchi-Sarfaty C; Hayward NK; Margulies EH; Samuels Y
Proc Natl Acad Sci U S A; 2013 Aug; 110(33):13481-6. PubMed ID: 23901115
[TBL] [Abstract][Full Text] [Related]
10. ERBB4 mutation analysis: emerging molecular target for melanoma treatment.
Lau C; Killian KJ; Samuels Y; Rudloff U
Methods Mol Biol; 2014; 1102():461-80. PubMed ID: 24258993
[TBL] [Abstract][Full Text] [Related]
11. Evidence That GRIN2A Mutations in Melanoma Correlate with Decreased Survival.
D'mello SA; Flanagan JU; Green TN; Leung EY; Askarian-Amiri ME; Joseph WR; McCrystal MR; Isaacs RJ; Shaw JH; Furneaux CE; During MJ; Finlay GJ; Baguley BC; Kalev-Zylinska ML
Front Oncol; 2014 Jan; 3():333. PubMed ID: 24455489
[TBL] [Abstract][Full Text] [Related]
12. Novel somatic mutations to PI3K pathway genes in metastatic melanoma.
Shull AY; Latham-Schwark A; Ramasamy P; Leskoske K; Oroian D; Birtwistle MR; Buckhaults PJ
PLoS One; 2012; 7(8):e43369. PubMed ID: 22912864
[TBL] [Abstract][Full Text] [Related]
13. A highly recurrent RPS27 5'UTR mutation in melanoma.
Dutton-Regester K; Gartner JJ; Emmanuel R; Qutob N; Davies MA; Gershenwald JE; Robinson W; Robinson S; Rosenberg SA; Scolyer RA; Mann GJ; Thompson JF; Hayward NK; Samuels Y
Oncotarget; 2014 May; 5(10):2912-7. PubMed ID: 24913145
[TBL] [Abstract][Full Text] [Related]
14. Whole-exome sequencing of oral mucosal melanoma reveals mutational profile and therapeutic targets.
Lyu J; Song Z; Chen J; Shepard MJ; Song H; Ren G; Li Z; Guo W; Zhuang Z; Shi Y
J Pathol; 2018 Mar; 244(3):358-366. PubMed ID: 29230811
[TBL] [Abstract][Full Text] [Related]
15. Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma.
Prickett TD; Wei X; Cardenas-Navia I; Teer JK; Lin JC; Walia V; Gartner J; Jiang J; Cherukuri PF; Molinolo A; Davies MA; Gershenwald JE; Stemke-Hale K; Rosenberg SA; Margulies EH; Samuels Y
Nat Genet; 2011 Sep; 43(11):1119-26. PubMed ID: 21946352
[TBL] [Abstract][Full Text] [Related]
16. Mutant IDH1 confers an in vivo growth in a melanoma cell line with BRAF mutation.
Shibata T; Kokubu A; Miyamoto M; Sasajima Y; Yamazaki N
Am J Pathol; 2011 Mar; 178(3):1395-402. PubMed ID: 21356389
[TBL] [Abstract][Full Text] [Related]
17. Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma.
Nikolaev SI; Rimoldi D; Iseli C; Valsesia A; Robyr D; Gehrig C; Harshman K; Guipponi M; Bukach O; Zoete V; Michielin O; Muehlethaler K; Speiser D; Beckmann JS; Xenarios I; Halazonetis TD; Jongeneel CV; Stevenson BJ; Antonarakis SE
Nat Genet; 2011 Dec; 44(2):133-9. PubMed ID: 22197931
[TBL] [Abstract][Full Text] [Related]
18. Missense Variants in the Histone Acetyltransferase Complex Component Gene TRRAP Cause Autism and Syndromic Intellectual Disability.
Cogné B; Ehresmann S; Beauregard-Lacroix E; Rousseau J; Besnard T; Garcia T; Petrovski S; Avni S; McWalter K; Blackburn PR; Sanders SJ; Uguen K; Harris J; Cohen JS; Blyth M; Lehman A; Berg J; Li MH; Kini U; Joss S; von der Lippe C; Gordon CT; Humberson JB; Robak L; Scott DA; Sutton VR; Skraban CM; Johnston JJ; Poduri A; Nordenskjöld M; Shashi V; Gerkes EH; Bongers EMHF; Gilissen C; Zarate YA; Kvarnung M; Lally KP; Kulch PA; Daniels B; Hernandez-Garcia A; Stong N; McGaughran J; Retterer K; Tveten K; Sullivan J; Geisheker MR; Stray-Pedersen A; Tarpinian JM; Klee EW; Sapp JC; Zyskind J; Holla ØL; Bedoukian E; Filippini F; Guimier A; Picard A; Busk ØL; Punetha J; Pfundt R; Lindstrand A; Nordgren A; Kalb F; Desai M; Ebanks AH; Jhangiani SN; Dewan T; Coban Akdemir ZH; Telegrafi A; Zackai EH; Begtrup A; Song X; Toutain A; Wentzensen IM; Odent S; Bonneau D; Latypova X; Deb W; ; Redon S; Bilan F; Legendre M; Troyer C; Whitlock K; Caluseriu O; Murphree MI; Pichurin PN; Agre K; Gavrilova R; Rinne T; Park M; Shain C; Heinzen EL; Xiao R; Amiel J; Lyonnet S; Isidor B; Biesecker LG; Lowenstein D; Posey JE; Denommé-Pichon AS; ; Férec C; Yang XJ; Rosenfeld JA; Gilbert-Dussardier B; Audebert-Bellanger S; Redon R; Stessman HAF; Nellaker C; Yang Y; Lupski JR; Goldstein DB; Eichler EE; Bolduc F; Bézieau S; Küry S; Campeau PM
Am J Hum Genet; 2019 Mar; 104(3):530-541. PubMed ID: 30827496
[TBL] [Abstract][Full Text] [Related]
19. Oncogenes in melanoma: an update.
Kunz M
Eur J Cell Biol; 2014; 93(1-2):1-10. PubMed ID: 24468268
[TBL] [Abstract][Full Text] [Related]
20. Whole-exome sequencing in an individual with severe global developmental delay and intractable epilepsy identifies a novel, de novo GRIN2A mutation.
Venkateswaran S; Myers KA; Smith AC; Beaulieu CL; Schwartzentruber JA; ; Majewski J; Bulman D; Boycott KM; Dyment DA
Epilepsia; 2014 Jul; 55(7):e75-9. PubMed ID: 24903190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
